Nutriband

NTRB · NASDAQ

$5.85−$0.15 (−2.50%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $6.00

Latest news

Press releaseOct 13, 8:00 AM ETGlobe Newswire
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
Press releaseOct 8, 7:00 AM ETGlobe Newswire
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
Press releaseOct 1, 4:05 PM ETGlobe Newswire
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Press releaseSep 29, 9:25 AM ETGlobe Newswire
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
NewsSep 28, 8:05 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsSep 28, 5:29 AM ETAvi Kapoor
Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Press releaseSep 25, 8:00 AM ETGlobe Newswire
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
Press releaseSep 22, 8:00 AM ETGlobe Newswire
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
Press releaseSep 9, 9:20 AM ETGlobe Newswire
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
Press releaseSep 8, 9:00 AM ETGlobe Newswire
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
NewsAug 24, 1:06 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
Press releaseAug 13, 7:00 AM ETGlobe Newswire
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
Press releaseMay 15, 7:00 AM ETGlobe Newswire
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
NewsMar 20, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseDec 31, 7:00 AM ETGlobe Newswire
Nutriband CEO Publishes Letter to Shareholders
NewsAug 8, 8:08 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsJul 2, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseJun 18, 8:45 AM ETGlobe Newswire
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
Press releaseMay 27, 8:00 AM ETGlobe Newswire
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.
NewsApr 30, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseApr 30, 7:30 AM ETGlobe Newswire
Nutriband CEO Publishes Letter to Shareholders
NewsFeb 7, 7:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseSep 24, 8:45 AM ETGlobe Newswire
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
NewsSep 17, 2:15 AM ETAvi Kapoor
Microsoft, Intel And 3 Stocks To Watch Heading Into Tuesday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274

Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology

Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders

Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis

12 Health Care Stocks Moving In Monday's Pre-Market Session

Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board

Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing

Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit

Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch

12 Health Care Stocks Moving In Monday's Intraday Session

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

12 Health Care Stocks Moving In Friday's Intraday Session

Nutriband CEO Publishes Letter to Shareholders

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.

12 Health Care Stocks Moving In Wednesday's Intraday Session

Nutriband CEO Publishes Letter to Shareholders

12 Health Care Stocks Moving In Friday's Pre-Market Session

As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

Microsoft, Intel And 3 Stocks To Watch Heading Into Tuesday